AkiyamaT., SudoC., OgawaraH., ToyoshimaK., YamamotoT.: The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase actvity. Science, 232: 1644–1646, 1986.
2.
HudziakR.M., SchlessingerJ., UlrichA.: Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA, 84: 7159–7163, 1987.
3.
CarterP., PrestaI, GormanC.M.: Humanization of an anti-p185 HER2 antibody for human cancer therapy. Proc Natl Acad Sci USA, 89: 4285–4289, 1992.
4.
BaselgaJ., TripathyD., MendelsohnJ.: Phase II study of weekly intravenous recombinant anti-p185 HER2 monoclonal antibody in patients with HER2/neu overexpressing metastatic breast cancer. J Clin Oncol, 14: 737–744, 1996.
5.
PegramM.D., LiptonA., HayesD.F.: Phase II study of receptor-enhanced chemosensivity using recombinant humanized anti-p185 HER2 monoclonal antibody plus cispaltin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol, 16: 2659–2671, 1998.
6.
CobleighM.A., VogelC.L., TripathyD.: Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2 overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol, 17: 2639–2648, 1999.
7.
SlamonD.J., Leyland-JonesB., ShakS.: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med, 11: 783–792, 2001.
8.
FyfeG., MassR, SlamonD.J.: Survival benefit of Herceptin (trastuzumab) and chemotherapy in older (age >60) patients. Br Ca Res Treat, 269(3): abs 526, 2001.
9.
BursteinH.J., KuterI., CamposS.M.: Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol, 19: 2722–2730, 2001.
10.
SeidmanA.D., FornierM.N., EstevaF.J.: Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol, 19: 2587–2595, 2001.
